Clinical trial · Observational
The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies
A Comparative Study to Examine the Accuracy of CHOLINE PET CT in the Diagnosis
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
PET CT is one of the imaging tools that are used for staging of urological malignancies. C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed \~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Urological Malignancies | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients older then 18 years of age * Full consciousness and awareness * suspected to suffer from urological malignancy and a candidate for a surgical procedur Exclusion Criteria: * known secondary malignancy
References
Publications (0)
Data not yet available